Search Results - "Neimann, Andrea"
-
1
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
Published in The New England journal of medicine (02-07-2020)“…The authors describe patients in New York City with known immune-mediated inflammatory disease in whom Covid-19 developed while they were receiving biologics,…”
Get full text
Journal Article -
2
COVID‐19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease‐Modifying Antirheumatic Drugs on Clinical Outcomes
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2020)“…Objective To characterize the hospitalization and death rates among patients with inflammatory arthritis (IA) affected by coronavirus disease 2019 (COVID‐19)…”
Get full text
Journal Article -
3
Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2020)“…OBJECTIVE:Patients with psoriasis have impaired vascular health and increased cardiovascular disease (CVD). Platelets are key players in the pathogenesis of…”
Get full text
Journal Article -
4
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
Published in European heart journal (01-04-2010)“…Aims Psoriasis is a common chronic inflammatory T-helper cell-1/17 mediated skin disease. Recent studies suggest that psoriasis, particularly if severe, may be…”
Get full text
Journal Article -
5
CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health
Published in Journal of the American Academy of Dermatology (01-04-2021)“…Psoriasis is associated with increased cardiovascular risk that is not captured by traditional proinflammatory biomarkers. To investigate the relationship…”
Get full text
Journal Article -
6
Risk of Myocardial Infarction in Patients With Psoriasis
Published in JAMA : the journal of the American Medical Association (11-10-2006)“…CONTEXT Psoriasis is the most common T-helper cell type 1 (TH1) immunological disease. Evidence has linked TH1 diseases to myocardial infarction (MI)…”
Get full text
Journal Article -
7
Interleukin‐17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin‐25–Driven Intestinal Inflammation
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-04-2020)“…Objective To characterize the ecological effects of biologic therapies on the gut bacterial and fungal microbiome in psoriatic arthritis…”
Get full text
Journal Article -
8
Inflammasome Signaling and Impaired Vascular Health in Psoriasis
Published in Arteriosclerosis, thrombosis, and vascular biology (01-04-2019)“…OBJECTIVE—Psoriasis is an inflammatory skin disease which heightens the risk of cardiovascular disease. This study directly investigated vascular endothelial…”
Get full text
Journal Article -
9
Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology–Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients
Published in Current rheumatology reports (01-01-2018)“…Purpose of Review Diagnosis and treatment of psoriatic arthritis (PsA) can be challenging and require a multidisciplinary approach. This review provides an…”
Get full text
Journal Article -
10
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin
Published in Annals of the rheumatic diseases (01-04-2023)“…To investigate the cutaneous microbiome spanning the entire psoriatic disease spectrum, and to evaluate distinguishing features of psoriasis (PsO) and…”
Get more information
Journal Article -
11
Prevalence of cardiovascular risk factors in patients with psoriasis
Published in Journal of the American Academy of Dermatology (01-11-2006)“…Previous studies suggest that patients hospitalized for psoriasis have an increased frequency of a variety of cardiovascular comorbidities. Limited…”
Get full text
Journal Article -
12
A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation
Published in Journal of investigative dermatology (01-06-2022)Get full text
Journal Article -
13
Racial and ethnic determinants of psoriatic arthritis phenotypes and disease activity
Published in Rheumatology (Oxford, England) (01-02-2024)“…Individuals of racially and ethnically diverse backgrounds are underrepresented in psoriatic arthritis (PsA) research/clinical trials, despite evidence that…”
Get full text
Journal Article -
14
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
Published in BMJ open (23-12-2022)“…Psoriatic arthritis (PsA) is a complex, immune-mediated disease associated with skin psoriasis that, if left untreated, can lead to joint destruction. Up to…”
Get full text
Journal Article -
15
Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers
Published in The Journal of dermatological treatment (03-04-2019)“…Injectable biologics (IB) are important in dermatology and we sought to examine the distribution of US IB-prescribing dermatologists. We used Centers for…”
Get full text
Journal Article -
16
The Risk of Lymphoma in Patients with Psoriasis
Published in Journal of investigative dermatology (01-10-2006)“…Psoriasis is a common, chronic, inflammatory disease. Psoriasis has been hypothesized to be associated with an increased risk of lymphoma due to its…”
Get full text
Journal Article -
17
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study
Published in Journal of rheumatology (01-08-2024)“…Psoriatic disease remains underdiagnosed and undertreated. We developed and validated a suite of novel, sensor-based smartphone assessments (Psorcast app) that…”
Get full text
Journal Article -
18
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Published in Journal of drugs in dermatology (01-08-2024)“…Plaque psoriasis is a chronic, relapsing systemic illness that has a significant effect on quality of life. Bimekizumab is the first monoclonal antibody to…”
Get more information
Journal Article -
19
Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems
Published in Science immunology (08-06-2023)“…Whereas the cellular and molecular features of human inflammatory skin diseases are well characterized, their tissue context and systemic impact remain poorly…”
Get more information
Journal Article -
20
Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center
Published in Journal of psoriasis and psoriatic arthritis (01-10-2023)“…Backgroud Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that, when left untreated, can lead to erosions, deformities and decrease in quality…”
Get full text
Journal Article